HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gaetane Nocturne Selected Research

Immune Checkpoint Inhibitors

5/2024Immune Checkpoint Inhibitor-induced Sicca Syndrome.
1/2022Features of polymyalgia rheumatica-like syndrome after immune checkpoint inhibitor therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gaetane Nocturne Research Topics

Disease

8Autoimmune Diseases (Autoimmune Disease)
11/2023 - 12/2013
7Lymphoma (Lymphomas)
10/2023 - 12/2013
6Rheumatoid Arthritis
11/2021 - 01/2016
5Inflammation (Inflammations)
08/2023 - 01/2019
3B-Cell Lymphoma (Lymphoma, B Cell)
01/2019 - 02/2015
2Neoplasms (Cancer)
01/2023 - 07/2021
2Corneal Ulcer
11/2021 - 01/2021
1Sjogren's Syndrome (Sjogren Syndrome)
05/2024
1Experimental Arthritis
08/2023
1Arthritis (Polyarthritis)
08/2023
1Keratoconjunctivitis Sicca
10/2022
1Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis)
01/2022
1Rheumatic Fever (Acute Articular Rheumatism)
01/2022
1Rheumatic Diseases (Rheumatism)
07/2021
1Skin Neoplasms (Skin Cancer)
07/2021
1Melanoma (Melanoma, Malignant)
07/2021
1Vasculitis (Vasculitides)
03/2021
1Atrioventricular Block
07/2020
1Sialadenitis
01/2019
1Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
01/2019
1Connective Tissue Diseases (Connective Tissue Disease)
01/2019
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
10/2017
1Back Pain (Backache)
01/2015
1Axial Spondyloarthritis
01/2015

Drug/Important Bio-Agent (IBA)

6Tumor Necrosis Factor InhibitorsIBA
07/2021 - 01/2017
4Biomarkers (Surrogate Marker)IBA
10/2022 - 01/2016
4Rituximab (Mabthera)FDA Link
01/2022 - 01/2019
3AntibodiesIBA
01/2021 - 10/2018
2Immune Checkpoint InhibitorsIBA
05/2024 - 01/2022
2Janus Kinase InhibitorsIBA
01/2023 - 07/2021
2AutoantibodiesIBA
07/2020 - 01/2019
1Molecular Probes (Molecular Probe)IBA
11/2023
1LigandsIBA
10/2023
1Agammaglobulinaemia Tyrosine KinaseIBA
10/2023
1Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
08/2023
1AntagomirsIBA
08/2023
1Liposomes (Liposome)IBA
08/2023
1RNA (Ribonucleic Acid)IBA
08/2023
1InterferonsIBA
12/2022
1COVID-19 VaccinesIBA
01/2022
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2022
1tocilizumab (atlizumab)FDA Link
11/2021
1tofacitinibIBA
07/2021
1Immunosuppressive Agents (Immunosuppressants)IBA
07/2021
1obinutuzumabIBA
03/2021
1Methotrexate (Mexate)FDA LinkGeneric
01/2021
1B-Cell Activating FactorIBA
01/2021
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
01/2021
1Rheumatoid FactorIBA
01/2021
1Macrophage Colony-Stimulating FactorIBA
10/2019
1Toll-Like Receptor AgonistsIBA
01/2019
1Bendamustine HydrochlorideFDA Link
01/2019
1anti-dsDNA autoantibodyIBA
01/2019
1Adenosine (Adenocard)FDA LinkGeneric
10/2018
1NF-kappa B (NF-kB)IBA
04/2016
1AntigensIBA
02/2015
1O,O-diisopropyl-S-benzylthiophosphate (IBP)IBA
01/2015
1DNA (Deoxyribonucleic Acid)IBA
12/2013
1Proteins (Proteins, Gene)FDA Link
12/2013

Therapy/Procedure

4Therapeutics
01/2022 - 06/2017
1Biological Therapy
10/2017